Physician profile
Michael S Hirsh
NPI 1346326428
$3,294.12
in general payments reported to CMS, 2019-2025
28 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.42 · 2020: $978 · 2021: $78.30 · 2022: $1,031 · 2023: $355 · 2024: $414 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $977.62 | 2020 | |
| Teleflex LLC | $966.40 | 2021-2022 | |
| Intuitive Surgical, INC. | $275.78 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $165.02 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $84.36 | 2019-2025 | Axonics, Rezum Generator |
| Astellas Pharma US INC | $83.78 | 2024-2025 | Xtandi |
| Astrazeneca Pharmaceuticals LP | $71.68 | 2023-2024 | Lynparza |
| Janssen Biotech, INC. | $62.33 | 2023-2025 | Erleada |
| Abbvie INC. | $51.47 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $47.85 | 2021-2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $46.19 | 2025 | |
| Tolmar, INC. | $44.34 | 2025 | Jatenzo, Eligard |
| Accord Healthcare, INC. | $41.89 | 2024-2025 | |
| Myovant Sciences INC. | $39.31 | 2021-2022 | |
| Pfizer INC. | $37.42 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $36.15 | 2023-2024 | Endosheath Technology |
| Ferring Pharmaceuticals INC. | $35.68 | 2025 | Adstiladrin |
| Axonics, INC. | $34.11 | 2022-2023 | Axonics |
| Antares Pharma, INC. | $29.94 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Blue Earth Diagnostics | $28.82 | 2021-2025 | Posluma |
| Allergan, INC. | $27.23 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $25.38 | 2025 | Bard Urinary Drainage Bag |
| Merck Sharp & Dohme LLC | $15.63 | 2023 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $15.14 | 2022 | |
| Urogen Pharma, INC. | $14.10 | 2024 | |
| Coloplast Corp | $13.34 | 2024 | |
| Karl Storz Endoscopy-America | $12.16 | 2021 | |
| Photocure INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hirsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.